장인호
#비뇨기종양#배뇨장애 복강경 및 로봇복강경수술
|
학력
1991.3~1997.2 : 중앙대학교 의과대학
1998.3~2000.2 : 중앙대학교 의과대학원 석사
2001.3~2005.8 : 중앙대학교 의과대학원 박사
1998.3~2000.2 : 중앙대학교 의과대학원 석사
2001.3~2005.8 : 중앙대학교 의과대학원 박사
경력
997.3~1998.2 : 중앙대학교병원 수련의
1998.3~2002.2 : 중앙대학교병원 비뇨기과 전공의
2002.5~2005.4 : 경기도 포천군 보건소 공중보건의
2005.5~2007.2 : 분당서울대학교병원 전임의
2007.3~2008.4 : 한일병원 비뇨기과 과장
2008.5~2010.2 : 중앙대학교병원 비뇨기과 진료조교수
2010.3~2012.2 : 중앙대학교병원 비뇨기과 조교수
2012.3~2017.2 : 중앙대학교병원 비뇨기과 부교수
2016.2~2017.2 : 미국 Wake Forest 대학 재생의학연구소 연구
2017.3~현재, 중앙대학교병원 비뇨의학과 교수
1998.3~2002.2 : 중앙대학교병원 비뇨기과 전공의
2002.5~2005.4 : 경기도 포천군 보건소 공중보건의
2005.5~2007.2 : 분당서울대학교병원 전임의
2007.3~2008.4 : 한일병원 비뇨기과 과장
2008.5~2010.2 : 중앙대학교병원 비뇨기과 진료조교수
2010.3~2012.2 : 중앙대학교병원 비뇨기과 조교수
2012.3~2017.2 : 중앙대학교병원 비뇨기과 부교수
2016.2~2017.2 : 미국 Wake Forest 대학 재생의학연구소 연구
2017.3~현재, 중앙대학교병원 비뇨의학과 교수
논문
1. Chang IH, Moon YT. The forgotten Double-J ureteral stent for 9 years Chung-Ang Med J 2000; 25: 161-4.
2. Chang IH, Kim TH, Kim YS. Effects of Cyclooxygenase-2 on Prostatic Cancer Cell Lines Korean Journal of Urology 2001; 42: 1101-7.
3. Chang IH, Seong YW, Myoung SC, Kim YS. Effects of Advanced Glycation End Products on Rat Bladder Fibroblast Korean Journal of Urology 2001; 42: 1204-10.
4. Chang IH, Yum SH, Kim KD, Lee YS. The Change of Enuresis in Children Korean Journal of Urology 2001; 42: 1080-6.
5. Chang IH, Yum SH, Myoung SC, Kim YS. Expression of Human Beta-Defensin in Human Male Urogenital Organs Infection 2001; 33: 233-41.
6. Yum SH, Jun IH, Jun HJ, Chang IH, Ahn SH, et al. Two Cases of Female Sexual Dysfunction Treated by Estrogen and Testosterone. Korean J Androl 2001; 19: 137-41.
7. Kim SC, Chang IH, Jeon HJ. Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year. BJU Int 2003; 92: 277-80.
8. Chang IH, Kim HS, Kim TH, Myoung SC, Lee SE, et al. The inhibition of human telomerase reverse transcriptase expression by peroxiredoxin I and c-Myc in prostatic cancer cells. Korean Journal of Urology 2006; 47: 418-25.
9. Chang IH, Kim TB, Gil MC, Kim YJ, Hong SK, et al. The clinicopathologic correlations of histologic tumor necrosis for the patients with renal cell carcinoma. Korean Journal of Urology 2006; 47: 449-55.
10. Gil MC, Chang IH, Kim YJ, Oh JK, Hong SK, et al. Clinicopathological significance of the lymphovascular invasion detected in specimens from radical retropubic prostatectomies. Korean Journal of Urology 2006; 47: 757-61.
11. Kim YJ, Chang IH, Gil MC, Hong SK, Byun SS, et al. Concordance of Gleason scores between prostate needle biopsy and radical prostatectomy specimens according to the number of biopsy cores. Korean Journal of Urology 2006; 47: 482-8.
12. Kim YJ, Lee SC, Chang IH, Gil MC, Hong SK, et al. Clinical significance of a single-core positive prostate cancers detected on extended prostate needle biopsy. Korean Journal of Urology 2006; 47: 475-81.
13. Lee SE, Byun SS, Hong SK, Chang IH, Kim YJ, et al. Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy. Urol Int 2006; 77: 13-7.
14. Lee SE, Byun SS, Hong SK, Lee HJ, Kim YJ, et al. Anatomical analysis of prostate and surrounding structures: Points to consider during radical retropubic prostatectomy. Korean Journal of Urology 2006; 47: 568-77.
15. Lee SE, Byun SS, Lee HJ, Song SH, Chang IH, et al. Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy. Urology 2006; 68: 137-41.
16. Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, et al. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol 2006; 176: 1332-7; discussion 7-8.
17. Lee SE, Byun SS, Park YH, Chang IH, Kim YJ, et al. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 2006; 77: 22-6.
18. Lee SE, Kwak C, Byun SS, Gill MC, Chang IH, et al. Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma. Urol Int 2006; 76: 256-63.
19. Bang SH, Chang IH, Han JH, Ahn SH. C-reactive protein is a useful marker to predict the severity and early response of acute pyelonephritis in women. Korean Journal of Urology 2007; 48: 1143-8.
20. Chang IH, Byun SS, Hong SK, Lee SE. Assessing the body mass index of patients might help to predict blood loss during radical retropubic prostatectomy in Korean men. BJU Int 2007; 99: 570-4.
21. Han BK, Choi WS, Yu JH, Han JH, Chang IH, et al. The characteristics of prostate cancer with metabolic syndrome in Korean men. Korean Journal of Urology 2007; 48: 585-91.
22. Han JH, Chang IH, Yu JH, Han BK, Jeong SJ, et al. Efficacy of radical retropubic prostatectomy in patients with clinically localized prostate cancer and a biopsy gleason score of 8 or higher. Korean Journal of Urology 2007; 48: 592-7.
23. Hong SK, Chang IH, Han BK, Yu JH, Han JH, et al. Impact of variations in bony pelvic dimensions on performing radical retropubic prostatectomy. Urology 2007; 69: 907-11.
24. Hong SK, Yu JH, Han BK, Chang IH, Jeong SJ, et al. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer. Urology 2007; 70: 91-5.
25. Jeong SJ, Chang IH, Han JH, Yu JH, Han BK, et al. A study on the incidence and preoperative predicting factors of extraprostatic extension in T1c prostate cancers. Korean Journal of Urology 2007; 48: 797-803.
26. Jeong SJ, Han BK, Yu JH, Han JH, Chang IH, et al. Development of nomogram for predicting pathologic outcome using prostate-specific antigen, Gleason score, and the percentage of positive core in the clinically confined prostate cancers, and comparison with nomogram using existing factors. Korean Journal of Urology 2007; 48: 789-96.
27. Jeong SJ, Han JH, Chang IH, Yu JH, Han BK, et al. Pathologic characteristics of prostate cancers missed by application of the age-specific prostate-specific antigen reference in men over sixties. Korean Journal of Urology 2007; 48: 809-14.
28. Yu JH, Cho YM, Chang IH, Han JH, Han BK, et al. Comparative analysis of the clinicopathological characteristics of patients with prostate cancer with a pathological Gleason score 3+4 versus Gleason score 4+3. Korean Journal of Urology 2007; 48: 804-8.
29. Yu JH, Lee JW, Chang IH, Han JH, Han BK, et al. The relationship of prostate volume and the grade of prostate cancer. Korean Journal of Urology 2007; 48: 1004-9.
30. Chang IH, Bang SH, Choi NY, Park SY, Han JH, et al. Trends in the emergence of ciprofloxacin-resistant Escherichia coli and the relationship with underlying diseases in patients with urinary tract infection. Korean Journal of Urology 2008; 49: 66-71.
31. Chang IH, Han JH, Ahn SH. Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men. J Urol 2008; 179: 886-90; discussion 90-1.
32. Chang IH, Kim TH. Role of Bacteria in Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Prostate update 2008.
33. Choi NY, Ahn SH, Han JH, Chang IH. The Effect of Tamsulosin and Nifedipine on Expulsion of Ureteral Stones after Extracorporeal Shock Wave Lithotripsy The Korean Journal of Urology 2008; 49: 150-4.
34. Han JH, Chang IH, Ahn SH, Kwon OJ, Bang SH, et al. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men. BJU Int 2008; 102: 1097-101.
35. Han JH, Choi NY, Bang SH, Kwon OJ, Jin YW, et al. Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men. Urology 2008; 72: 749-54; discussion 54-5.
36. Shin HO, Kim YS, Kim KD, Chang IH, Lee SY, et al. Characteristics of Incidentally Detected Renal Cell Carcinoma The Korean Journal of Urology 2008; 49: 675-81.
37. Chang IH. Editorial comment. J Urol 2009; 182: 2651.
38. Chang IH, Ahn SH, Han JH, Kim TH, Kim YS, et al. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration. J Urol 2009; 181: 567-72; discussion 72-3.
39. Chang IH, Han JH, Myung SC, Kwak KW, Kim TH, et al. Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology 2009; 14: 321-6.
40. Chang IH, Oh SY, Kim SC. A possible relationship between testosterone and lower urinary tract symptoms in men. J Urol 2009; 182: 215-20.
41. Chung WH, Kim TH, Chang IH, Myung SC. Relation of Resistin to Prostate Cancer Differentiation and Aggressiveness. Korean Journal of Urology 2009; 50: 540-52.
42. Kim TH, Chang IH, Kim TH, Lee SY, Myung SC. Extramammary Paget's disease of scrotum treated with radiotherapy. Urology 2009; 74: 474 e1-3.
43. Kwon JK, Chang IH, Kim TH, Myoung SC. Changes in Prostate Cancer Pattern according to Prostate-Specific Antigen Screening Test Korean Journal of Urology 2009; 50: 439-44.
44. Lee SY, Park SJ, Chang IH, Myoung SC, Kim TH. The Effects of Adiponectin and Leptin in the Proliferation of Prostate Cancer Cells Korean Journal of Urology 2009; 50: 493-7.
45. Park SW, Chang IH, Han JH, Kawk KW, Ahn SH. The significance of persistent abnormal urine cytology. Korean Journal of Urology 2009; 50: 125-9.
46. Shin TS, Kim TH, Chang IH, Myung SC, Kim KD. The clinical significance of serum and urine cytokines in patients with acute uncomplicated pyelonephritis. Korean Journal of Urology 2009; 50: 33-8.
47. Chang IH, Ha MS, Chi BH, Kown YW, Lee SJ. Warfarin-induced penile necrosis in a patient with heparin-induced thrombocytopenia. J Korean Med Sci 2010; 25: 1390-3.
48. Chi BH, Chang IH. Prostate cancer: recent trends in Korea. Urol Int 2010; 85: 88-93.
49. Ha MS, Chang IH. Significance of age and comorbidity as prognostic indicators for patients with bladder cancer. Asian J Androl 2010; 12: 766-74.
50. Han JH, Lee MY, Lee SY, Chang IH, Kim HJ, et al. Effect of low concentrations of hydrogen peroxide on the contractile responses of rat detrusor smooth muscle strips. Eur J Pharmacol 2010; 638: 115-20.
51. Han JH, Lee YT, Kwak KW, Ahn SH, Chang IH, et al. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men. Asian J Androl 2010; 12: 400-4.
52. Kwon YW, Chang IH, Kim KD, Kim YS, Myung SC, et al. Significance of S100A2 and S100A4 Expression in the Progression of Prostate Adenocarcinoma. Korean J Urol 2010; 51: 456-62.
53. Lee SY, Kim JY, Park SJ, Kwon YW, Nguyen HB, et al. Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence. Korean J Urol 2010; 51: 657-9.
54. Chang IH, Lee YT, Lee DM, Kim TH, Myung SC, et al. Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men without hypertension and diabetes. Urology 2011; 78: 753-8.
55. Choi SY, Chang IH, Kim YS, Kim TH, Kim W, et al. Prostate specific antigen velocity per prostate volume: a novel tool for prostate biopsy prediction. Urology 2011; 78: 874-9.
56. Jung HS, Chang IH, Kim KD, Moon YT, Kim TH, et al. Possible Relationship between Metabolic Syndrome Traits and Nephrolithiasis: Incidence for 15 Years According to Gender. Korean J Urol 2011; 52: 548-53.
57. Kim HJ, Bae JS, Lee J, Chang IH, Kim KD, et al. HNF1B polymorphism associated with development of prostate cancer in Korean patients. Urology 2011; 78: 969 e1-6.
58. Kim HJ, Jung JR, Kim HJ, Lee SY, Chang IH, et al. Expression of human beta-defensin-2 in the prostate. BJU Int 2011; 107: 144-9.
59. Kim HJ, Lee J, Han JH, Lee JY, Chang IH, et al. Association between LEP Gene Polymorphisms and Prostate Cancer Susceptibility in Korean Men. The Korean Journal of Urological Oncology 2011; 9: 112-8.
60. Kim HJ, Lee YS, Won EH, Chang IH, Kim TH, et al. Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int 2011; 108: E77-83.
61. Kim JY, Kim YS, Chang IH, Kim TH, Kim HR. Interleukin-1beta, calcium-sensing receptor, and urokinase gene polymorphisms in korean patients with urolithiasis. Korean J Urol 2011; 52: 340-4.
62. Lee JY, Chang IH, Moon YT, Kim KD, Myung SC, et al. Effect of Prostate Biopsy Hemorrhage on MRDW and MRS Imaging. Korean J Urol 2011; 52: 674-80.
63. Park SJ, Lee TJ, Chang IH. Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study. Korean J Urol 2011; 52: 466-73.
64. Choi SY, Kim TH, Myung SC, Moon YT, Kim KD, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean J Urol 2012; 53: 23-8.
65. Chung JD, Kim TH, Myung SC, Moon YT, Kim KD, et al. Influence of overweight on 24-hour urine chemistry studies and recurrent urolithiasis in children. Korean J Urol 2012; 53: 268-74.
66. Han JH, Chang IH, Myung SC, Lee MY, Kim WY, et al. A novel pathway underlying the inhibitory effects of melatonin on isolated rat urinary bladder contraction. Korean J Physiol Pharmacol 2012; 16: 37-42.
67. Kim HJ, Bae JS, Chang IH, Kim KD, Lee J, et al. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men. World J Urol 2012; 30: 225-32.
68. Kim HJ, Han JH, Chang IH, Kim W, Myung SC. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer. Prostate Cancer Prostatic Dis 2012.
69. Kim HJ, Lee J, Chang IH, Kim TH, Kim KD, et al. RNASEL Gene Polymorphisms are Associated with PSA Level and Prostatic Volume in Korean Men with Benign Prostatic Hyperplasia. The Korean Journal of Urological Oncology 2012; 10: 130-7.
70. Kim HJ, Lee J, Han JH, Lee JY, Chang IH, et al. Variants in Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Gene are Associated with Susceptibility to Prostate Cancer. The Korean Journal of Urological Oncology 2012; 1-: 27-33.
71. Kim JH, Chang IH. Epidemiology of Antimicrobial-Resistance in Sexually Transmitted Infections in Korea: Implications for Rational Treatment. Korean J UTII 2012; 7: 106-20.
72. Kim JH, Ha YC, Kim TH, Myung SC, Moon YT, et al. Delayed presentation of intravesical bone penetration after pelvic ring fracture. Korean J Urol 2012; 53: 887-9.
73. Kim JH, Kim SJ, Lee KM, Chang IH. Human beta-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells. BJU Int 2013.
74. Lee JY, Oh SY, Chang IH, Choe JW, Park SH, et al. Laparoscopic repair of large bladder herniation presenting as an inguinal hernia. Korean J Urol 2013; 54: 139-42.
75. Lee SH, Chang IH, Kim TH, Myung SC, Moon YT, et al. Histopathological Evaluation of Non-Neoplastic Renal Parenchyma Adjacent to Tumors in Partial Nephrectomy Specimens of Renal Cell Carcinoma. The Korean Journal of Urological Oncology 2013; 11: 33-40.
76. Lee SH, Kim TH, Myung SC, Moon YT, Kim KD, et al. Effectiveness of flexible ureteroscopic stone removal for treating ureteral and ipsilateral renal stones: a single-center experience. Korean J Urol 2013; 54: 377-82.
77. Nguyen HB, Lee SY, Park SH, Lee MY, Chang IH, et al. Relaxing effect of acetylcholine on phenylephrine-induced contraction of isolated rabbit prostate strips is mediated by neuronal nitric oxide synthase. Korean J Urol 2013; 54: 333-8.
78. Park SH, Kwon JK, Chang IH, Kim JH, Lim SW. Non-Epithelioid Renal Angiomyolipoma with Renal Vein and Inferior Vena Cava Invasion. The Korean Journal of Urological Oncology 2013; 11: 41-4.
79. Kwon JK, Chang IH. Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome. Int Neurourol J. 2013 Jun;17(2):48-58.
80. Nguyen HB, Myung SC, Lee SY, Kim KD, Chang IH, Lee JY, Choe JW, Ryu JH, Park SH. Outcomes of free-tension transobturator tape (TOT) surgery under local anesthesia versus general anesthesia for female stress incontinent treatment. Chung-Ang journal of medicine. 2011 Dec; 36(3):61-69
81. Jung SH, Choi SY, Kim JY, Lee SH, Chung JD, Choi JW, Chang IH. Temporary Vena Cava Filter Placement to Prevent Tumor Emboli During Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma. Chung-Ang journal of medicine. 2010 Dec;35(3):61-66
82. Kim JH, Kwon JK, Chang IH, Current Opinions Regarding Defense Mechanisms during Urinary Tract Infection Korean J Urogenit Tract Infect Inflamm 2013;8(2): 63-72
83. Kwon JK, Kim SJ, Kim JH, Lee KM, Chang IH, Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer. Urol Oncol 2014
84. Kim SJ, Kim JH, Jung HS, Lee TJ, Lee KM, Chang IH, Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence. Asian J Androl. 2014 Mar 11
85. Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chi BH, Chang IH, Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the Mammalian target of rapamycin signaling pathway. J Korean Med Sci. 2014 Mar;29(3):343-50
86. Chi BH, Chang IH, Current understanding of bladder immune response to BCG therapy. The Korean Journal of Urological Oncology. 2014
87. Chung JD, Lee JB, Lee TJ, Kwon JK, Kin JH, Chang IH, Kim KD, Histopathological differences between prostate cancer foci that are detected and missed using multiparametric magnetic resonance imaging in Korean patients. IJU 2014
88. Min-kyoung Kim, Hyun Kang, Chong Wha Baek, Yong Hun Jung, Young-Cheol Woo, Hwa-Yong Shin, and In-ho. Chang. Apnothorax during urologic laparoscopic surgery ?A case report? Anesth Pain Med 2014; 9: 73-76
89. Seo Yeon Lee, Hae jong Kim1, In Ho Chang2, June Hyun Han3, Kyung Do Kim2, Young Tae Moon2, Soon Chul Myung2,4 Modulation of Antimicrobial Peptide Human β-defensin-3 by Toll-like Receptor Ligands in Vaginal Epithelial Cells. Korean J Urogenit Tract Infect Inflamm 2014; 9 (1) :27-33
90. Min Su Kim1, Tae-Jin Lee2, Hee-Jun Kim3, Sung Bin Park4, Jin Hwa Choi5, In Ho Chang6 Primary Synovial Sarcoma of the Kidney with Unusual Recurrence: Ureteral Stump Recurrence after Radical Nephrectomy Korean J Urol Oncol 2014;12(2):89-94
91. Mack Shin ? Sung Bin Park ? Jong Beum Lee ? Hyun Jeong Park ? In Ho Chang ? Tae-Jin Lee. Unilateral renal oncocytosis and combined hybrid tumor: a case report and review of the literature. Jpn J Radiol (2014) 32:556?560
92. A prospective korean multicenter study for infectious complications in patients undergoing prostate surgery: risk factors and efficacy of antibiotic prophylaxis. Hwang EC, Jung SI, Kwon DD, Lee G, Bae JH, Na YG, Min SK, Son H, Lee SJ, Chung JM, Chung H, Cho IR, Kim YH, Kim TH, Chang IH. J Korean Med Sci. 2014 Sep;29(9):1271-7.
93. Pilot study of low-dose nonenhanced computed tomography with iterative reconstruction for diagnosis of urinary stones. Park SH, Kim KD, Moon YT, Myung SC, Kim TH, Chang IH, Kwon JK. Korean J Urol. 2014 Sep;55(9):581-6.
94. Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models. Choi SY, Ryu JH, Chang IH, Kim TH, Myung SC, Moon YT, Kim KD, Kim JW. Korean J Urol. 2014 Oct;55(10):643-9.
95. Febrile urinary tract infection after prostate biopsy and quinolone resistance. Choi JW, Kim TH, Chang IH, Kim KD, Moon YT, Myung SC, Kim JW, Kim MS, Kwon JK. Korean J Urol. 2014 Oct;55(10):660-4.
96. Voiding characteristics and related hormonal changes inperi-menopausal and post-menopausal women: A preliminary study. Jong Kyu Kwona, Jae Heon Kimb,?, Hoon Choic, In Ho Changa, Bo Ra Parkd,Soon-Sun Kwone, Eun Sil Leed, Gyu Yeon Choid, Jeong Jae Leed, Im Soon Lee. Maturitas 2014 Nov;79:311-5
97. P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model. Chi BH, Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chang IH. J Korean Med Sci. 2015 Mar;30(3):308-16.
98. Usefulness of Low-dose Nonenhanced Computed Tomography With Iterative Reconstruction for Evaluation of Urolithiasis: Diagnostic Performance and Agreement between the Urologist and the Radiologist. Kwon JK, Chang IH, Moon YT, Lee JB, Park HJ, Park SB. Urology. 2015 Mar;85(3):531-8.
99. Modulating the internalization of bacille calmette-guerin by cathelicidin in bladder cancer cells. ,Choi SY, Kim SJ, Chi BH, Kwon JK, Chang IH. Urology. 2015 Apr;85(4):964.e7-964.e12.
100. Murine β-defensin-2 may regulate the effect of bacillus Calmette-Guerin (BCG) in normal mouse bladder. Kwon JK, Chi BH, Choi SY, Kim SJ, Lee TJ, Kim K, Chang IH. Urol Oncol. 2015 Mar;33(3):111.e9-111.e16.
101. Sonographic findings of prescrotal superficial angiomyxoma.Lee CU, Park SB, Lee JB, Park HJ, Kim MK, Chang IH. Jpn J Radiol. 2015 Apr;33(4):216-9.
102. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women. Park M, Chang IH, Kang H, Han SS. J Obstet Gynaecol Res. 2015 May;41(5):784-9
103. Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors. Choi SY, Chang IH. Korean J Urol Oncol. 2015 Apr;13(1):1-10.
104. Establishment of Reference Ranges for Prostate Volume and Annual Prostate Volume Change Rate in Korean Adult Men: Analyses of a Nationwide Screening Population. Park J, Lee DG, Suh B, Cho SY, Chang IH, Paick SH, Lee HL. J Korean Med Sci. 2015 Aug;30(8):1136-42
105. The Internalization of Bacillus Calmette-Guerin (BCG) in Bladder Cancer Cells May be Inhibited by Human beta-defensin 3. Lim SW, Chang IH, Kim TH, Myung SC, Kim KD, Moon YT, Kim JW, Chi BH. Korean J Urol Oncol. 2015 Aug;13(2):75-84. English.
106. Usefulness of Nonenhanced Computed Tomography for Diagnosing Urolithiasis without Pyuria in the Emergency Department. Lee DH, Chang IH, Kim JW, Chi BH, Park SB. Biomed Res Int. 2015;2015:810971.
107. CT for evaluation of urolithiasis: image quality of ultralow-dose (Sub mSv) CT with knowledge-based iterative reconstruction and diagnostic performance of low-dose CT with statistical iterative reconstruction. Hur J, Park SB, Lee JB, Park HJ, Chang IH, Kwon JK, Kim YS. Abdom Imaging. 2015 Oct;40(7):2432-40.
108. Molecular Defense Mechanisms during Urinary Tract Infection. Urogenit Tract Infect. Choi SY, Chang IH. 2015 Oct;10(2):57-66.
109. Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study.Shim SR, Kim JH, Chang IH, Shin IS, Hwang SD, Kim KH, Yoon SJ, Song YS. Yonsei Med J. 2016 Mar;57(2):407-18.
110. Daily Mean Temperature Affects Urolithiasis Presentation in Seoul: a Time-series Analysis. Lee S, Kim MS, Kim JH, Kwon JK, Chi BH, Kim JW, Chang IH. J Korean Med Sci. 2016 May;31(5):750-6.
111. Human Neural Stem Cells Overexpressing a Carboxylesterase Inhibit Bladder Tumor Growth. Choi SS, Chi BH, Chang IH, Kim KD, Lee SR, Kim SU, Lee HJ. Mol Cancer Ther. 2016 Jun;15(6):1201-7.
112. Genetically Modified Bacteria as Targeted Agent for Cancer. Jin S, Whang YM, Chang IH. Korean J Urol Oncol. 2016 Aug;14(2):54-62.
113. Recombinant Bacille Calmette?Guerin for Immunotherapy in Nonmuscle Invasive Bladder Cancer. Jin S, Whang YM, Chang IH. Korean J Urol Oncol. 2016 Dec;14(3):109-117.
114. Urbanization may affect the incidence of urolithiasis in South Korea. Choi SY, Lee SY, Chi BH, Kim JW, Kim TH, Chang IH. Springerplus. 2016 Oct 28;5(1):1891.
2. Chang IH, Kim TH, Kim YS. Effects of Cyclooxygenase-2 on Prostatic Cancer Cell Lines Korean Journal of Urology 2001; 42: 1101-7.
3. Chang IH, Seong YW, Myoung SC, Kim YS. Effects of Advanced Glycation End Products on Rat Bladder Fibroblast Korean Journal of Urology 2001; 42: 1204-10.
4. Chang IH, Yum SH, Kim KD, Lee YS. The Change of Enuresis in Children Korean Journal of Urology 2001; 42: 1080-6.
5. Chang IH, Yum SH, Myoung SC, Kim YS. Expression of Human Beta-Defensin in Human Male Urogenital Organs Infection 2001; 33: 233-41.
6. Yum SH, Jun IH, Jun HJ, Chang IH, Ahn SH, et al. Two Cases of Female Sexual Dysfunction Treated by Estrogen and Testosterone. Korean J Androl 2001; 19: 137-41.
7. Kim SC, Chang IH, Jeon HJ. Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year. BJU Int 2003; 92: 277-80.
8. Chang IH, Kim HS, Kim TH, Myoung SC, Lee SE, et al. The inhibition of human telomerase reverse transcriptase expression by peroxiredoxin I and c-Myc in prostatic cancer cells. Korean Journal of Urology 2006; 47: 418-25.
9. Chang IH, Kim TB, Gil MC, Kim YJ, Hong SK, et al. The clinicopathologic correlations of histologic tumor necrosis for the patients with renal cell carcinoma. Korean Journal of Urology 2006; 47: 449-55.
10. Gil MC, Chang IH, Kim YJ, Oh JK, Hong SK, et al. Clinicopathological significance of the lymphovascular invasion detected in specimens from radical retropubic prostatectomies. Korean Journal of Urology 2006; 47: 757-61.
11. Kim YJ, Chang IH, Gil MC, Hong SK, Byun SS, et al. Concordance of Gleason scores between prostate needle biopsy and radical prostatectomy specimens according to the number of biopsy cores. Korean Journal of Urology 2006; 47: 482-8.
12. Kim YJ, Lee SC, Chang IH, Gil MC, Hong SK, et al. Clinical significance of a single-core positive prostate cancers detected on extended prostate needle biopsy. Korean Journal of Urology 2006; 47: 475-81.
13. Lee SE, Byun SS, Hong SK, Chang IH, Kim YJ, et al. Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy. Urol Int 2006; 77: 13-7.
14. Lee SE, Byun SS, Hong SK, Lee HJ, Kim YJ, et al. Anatomical analysis of prostate and surrounding structures: Points to consider during radical retropubic prostatectomy. Korean Journal of Urology 2006; 47: 568-77.
15. Lee SE, Byun SS, Lee HJ, Song SH, Chang IH, et al. Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy. Urology 2006; 68: 137-41.
16. Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, et al. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol 2006; 176: 1332-7; discussion 7-8.
17. Lee SE, Byun SS, Park YH, Chang IH, Kim YJ, et al. Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 2006; 77: 22-6.
18. Lee SE, Kwak C, Byun SS, Gill MC, Chang IH, et al. Metastatectomy prior to immunochemotherapy for metastatic renal cell carcinoma. Urol Int 2006; 76: 256-63.
19. Bang SH, Chang IH, Han JH, Ahn SH. C-reactive protein is a useful marker to predict the severity and early response of acute pyelonephritis in women. Korean Journal of Urology 2007; 48: 1143-8.
20. Chang IH, Byun SS, Hong SK, Lee SE. Assessing the body mass index of patients might help to predict blood loss during radical retropubic prostatectomy in Korean men. BJU Int 2007; 99: 570-4.
21. Han BK, Choi WS, Yu JH, Han JH, Chang IH, et al. The characteristics of prostate cancer with metabolic syndrome in Korean men. Korean Journal of Urology 2007; 48: 585-91.
22. Han JH, Chang IH, Yu JH, Han BK, Jeong SJ, et al. Efficacy of radical retropubic prostatectomy in patients with clinically localized prostate cancer and a biopsy gleason score of 8 or higher. Korean Journal of Urology 2007; 48: 592-7.
23. Hong SK, Chang IH, Han BK, Yu JH, Han JH, et al. Impact of variations in bony pelvic dimensions on performing radical retropubic prostatectomy. Urology 2007; 69: 907-11.
24. Hong SK, Yu JH, Han BK, Chang IH, Jeong SJ, et al. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer. Urology 2007; 70: 91-5.
25. Jeong SJ, Chang IH, Han JH, Yu JH, Han BK, et al. A study on the incidence and preoperative predicting factors of extraprostatic extension in T1c prostate cancers. Korean Journal of Urology 2007; 48: 797-803.
26. Jeong SJ, Han BK, Yu JH, Han JH, Chang IH, et al. Development of nomogram for predicting pathologic outcome using prostate-specific antigen, Gleason score, and the percentage of positive core in the clinically confined prostate cancers, and comparison with nomogram using existing factors. Korean Journal of Urology 2007; 48: 789-96.
27. Jeong SJ, Han JH, Chang IH, Yu JH, Han BK, et al. Pathologic characteristics of prostate cancers missed by application of the age-specific prostate-specific antigen reference in men over sixties. Korean Journal of Urology 2007; 48: 809-14.
28. Yu JH, Cho YM, Chang IH, Han JH, Han BK, et al. Comparative analysis of the clinicopathological characteristics of patients with prostate cancer with a pathological Gleason score 3+4 versus Gleason score 4+3. Korean Journal of Urology 2007; 48: 804-8.
29. Yu JH, Lee JW, Chang IH, Han JH, Han BK, et al. The relationship of prostate volume and the grade of prostate cancer. Korean Journal of Urology 2007; 48: 1004-9.
30. Chang IH, Bang SH, Choi NY, Park SY, Han JH, et al. Trends in the emergence of ciprofloxacin-resistant Escherichia coli and the relationship with underlying diseases in patients with urinary tract infection. Korean Journal of Urology 2008; 49: 66-71.
31. Chang IH, Han JH, Ahn SH. Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men. J Urol 2008; 179: 886-90; discussion 90-1.
32. Chang IH, Kim TH. Role of Bacteria in Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Prostate update 2008.
33. Choi NY, Ahn SH, Han JH, Chang IH. The Effect of Tamsulosin and Nifedipine on Expulsion of Ureteral Stones after Extracorporeal Shock Wave Lithotripsy The Korean Journal of Urology 2008; 49: 150-4.
34. Han JH, Chang IH, Ahn SH, Kwon OJ, Bang SH, et al. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men. BJU Int 2008; 102: 1097-101.
35. Han JH, Choi NY, Bang SH, Kwon OJ, Jin YW, et al. Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men. Urology 2008; 72: 749-54; discussion 54-5.
36. Shin HO, Kim YS, Kim KD, Chang IH, Lee SY, et al. Characteristics of Incidentally Detected Renal Cell Carcinoma The Korean Journal of Urology 2008; 49: 675-81.
37. Chang IH. Editorial comment. J Urol 2009; 182: 2651.
38. Chang IH, Ahn SH, Han JH, Kim TH, Kim YS, et al. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration. J Urol 2009; 181: 567-72; discussion 72-3.
39. Chang IH, Han JH, Myung SC, Kwak KW, Kim TH, et al. Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology 2009; 14: 321-6.
40. Chang IH, Oh SY, Kim SC. A possible relationship between testosterone and lower urinary tract symptoms in men. J Urol 2009; 182: 215-20.
41. Chung WH, Kim TH, Chang IH, Myung SC. Relation of Resistin to Prostate Cancer Differentiation and Aggressiveness. Korean Journal of Urology 2009; 50: 540-52.
42. Kim TH, Chang IH, Kim TH, Lee SY, Myung SC. Extramammary Paget's disease of scrotum treated with radiotherapy. Urology 2009; 74: 474 e1-3.
43. Kwon JK, Chang IH, Kim TH, Myoung SC. Changes in Prostate Cancer Pattern according to Prostate-Specific Antigen Screening Test Korean Journal of Urology 2009; 50: 439-44.
44. Lee SY, Park SJ, Chang IH, Myoung SC, Kim TH. The Effects of Adiponectin and Leptin in the Proliferation of Prostate Cancer Cells Korean Journal of Urology 2009; 50: 493-7.
45. Park SW, Chang IH, Han JH, Kawk KW, Ahn SH. The significance of persistent abnormal urine cytology. Korean Journal of Urology 2009; 50: 125-9.
46. Shin TS, Kim TH, Chang IH, Myung SC, Kim KD. The clinical significance of serum and urine cytokines in patients with acute uncomplicated pyelonephritis. Korean Journal of Urology 2009; 50: 33-8.
47. Chang IH, Ha MS, Chi BH, Kown YW, Lee SJ. Warfarin-induced penile necrosis in a patient with heparin-induced thrombocytopenia. J Korean Med Sci 2010; 25: 1390-3.
48. Chi BH, Chang IH. Prostate cancer: recent trends in Korea. Urol Int 2010; 85: 88-93.
49. Ha MS, Chang IH. Significance of age and comorbidity as prognostic indicators for patients with bladder cancer. Asian J Androl 2010; 12: 766-74.
50. Han JH, Lee MY, Lee SY, Chang IH, Kim HJ, et al. Effect of low concentrations of hydrogen peroxide on the contractile responses of rat detrusor smooth muscle strips. Eur J Pharmacol 2010; 638: 115-20.
51. Han JH, Lee YT, Kwak KW, Ahn SH, Chang IH, et al. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men. Asian J Androl 2010; 12: 400-4.
52. Kwon YW, Chang IH, Kim KD, Kim YS, Myung SC, et al. Significance of S100A2 and S100A4 Expression in the Progression of Prostate Adenocarcinoma. Korean J Urol 2010; 51: 456-62.
53. Lee SY, Kim JY, Park SJ, Kwon YW, Nguyen HB, et al. Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence. Korean J Urol 2010; 51: 657-9.
54. Chang IH, Lee YT, Lee DM, Kim TH, Myung SC, et al. Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men without hypertension and diabetes. Urology 2011; 78: 753-8.
55. Choi SY, Chang IH, Kim YS, Kim TH, Kim W, et al. Prostate specific antigen velocity per prostate volume: a novel tool for prostate biopsy prediction. Urology 2011; 78: 874-9.
56. Jung HS, Chang IH, Kim KD, Moon YT, Kim TH, et al. Possible Relationship between Metabolic Syndrome Traits and Nephrolithiasis: Incidence for 15 Years According to Gender. Korean J Urol 2011; 52: 548-53.
57. Kim HJ, Bae JS, Lee J, Chang IH, Kim KD, et al. HNF1B polymorphism associated with development of prostate cancer in Korean patients. Urology 2011; 78: 969 e1-6.
58. Kim HJ, Jung JR, Kim HJ, Lee SY, Chang IH, et al. Expression of human beta-defensin-2 in the prostate. BJU Int 2011; 107: 144-9.
59. Kim HJ, Lee J, Han JH, Lee JY, Chang IH, et al. Association between LEP Gene Polymorphisms and Prostate Cancer Susceptibility in Korean Men. The Korean Journal of Urological Oncology 2011; 9: 112-8.
60. Kim HJ, Lee YS, Won EH, Chang IH, Kim TH, et al. Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int 2011; 108: E77-83.
61. Kim JY, Kim YS, Chang IH, Kim TH, Kim HR. Interleukin-1beta, calcium-sensing receptor, and urokinase gene polymorphisms in korean patients with urolithiasis. Korean J Urol 2011; 52: 340-4.
62. Lee JY, Chang IH, Moon YT, Kim KD, Myung SC, et al. Effect of Prostate Biopsy Hemorrhage on MRDW and MRS Imaging. Korean J Urol 2011; 52: 674-80.
63. Park SJ, Lee TJ, Chang IH. Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study. Korean J Urol 2011; 52: 466-73.
64. Choi SY, Kim TH, Myung SC, Moon YT, Kim KD, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean J Urol 2012; 53: 23-8.
65. Chung JD, Kim TH, Myung SC, Moon YT, Kim KD, et al. Influence of overweight on 24-hour urine chemistry studies and recurrent urolithiasis in children. Korean J Urol 2012; 53: 268-74.
66. Han JH, Chang IH, Myung SC, Lee MY, Kim WY, et al. A novel pathway underlying the inhibitory effects of melatonin on isolated rat urinary bladder contraction. Korean J Physiol Pharmacol 2012; 16: 37-42.
67. Kim HJ, Bae JS, Chang IH, Kim KD, Lee J, et al. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men. World J Urol 2012; 30: 225-32.
68. Kim HJ, Han JH, Chang IH, Kim W, Myung SC. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer. Prostate Cancer Prostatic Dis 2012.
69. Kim HJ, Lee J, Chang IH, Kim TH, Kim KD, et al. RNASEL Gene Polymorphisms are Associated with PSA Level and Prostatic Volume in Korean Men with Benign Prostatic Hyperplasia. The Korean Journal of Urological Oncology 2012; 10: 130-7.
70. Kim HJ, Lee J, Han JH, Lee JY, Chang IH, et al. Variants in Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Gene are Associated with Susceptibility to Prostate Cancer. The Korean Journal of Urological Oncology 2012; 1-: 27-33.
71. Kim JH, Chang IH. Epidemiology of Antimicrobial-Resistance in Sexually Transmitted Infections in Korea: Implications for Rational Treatment. Korean J UTII 2012; 7: 106-20.
72. Kim JH, Ha YC, Kim TH, Myung SC, Moon YT, et al. Delayed presentation of intravesical bone penetration after pelvic ring fracture. Korean J Urol 2012; 53: 887-9.
73. Kim JH, Kim SJ, Lee KM, Chang IH. Human beta-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells. BJU Int 2013.
74. Lee JY, Oh SY, Chang IH, Choe JW, Park SH, et al. Laparoscopic repair of large bladder herniation presenting as an inguinal hernia. Korean J Urol 2013; 54: 139-42.
75. Lee SH, Chang IH, Kim TH, Myung SC, Moon YT, et al. Histopathological Evaluation of Non-Neoplastic Renal Parenchyma Adjacent to Tumors in Partial Nephrectomy Specimens of Renal Cell Carcinoma. The Korean Journal of Urological Oncology 2013; 11: 33-40.
76. Lee SH, Kim TH, Myung SC, Moon YT, Kim KD, et al. Effectiveness of flexible ureteroscopic stone removal for treating ureteral and ipsilateral renal stones: a single-center experience. Korean J Urol 2013; 54: 377-82.
77. Nguyen HB, Lee SY, Park SH, Lee MY, Chang IH, et al. Relaxing effect of acetylcholine on phenylephrine-induced contraction of isolated rabbit prostate strips is mediated by neuronal nitric oxide synthase. Korean J Urol 2013; 54: 333-8.
78. Park SH, Kwon JK, Chang IH, Kim JH, Lim SW. Non-Epithelioid Renal Angiomyolipoma with Renal Vein and Inferior Vena Cava Invasion. The Korean Journal of Urological Oncology 2013; 11: 41-4.
79. Kwon JK, Chang IH. Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome. Int Neurourol J. 2013 Jun;17(2):48-58.
80. Nguyen HB, Myung SC, Lee SY, Kim KD, Chang IH, Lee JY, Choe JW, Ryu JH, Park SH. Outcomes of free-tension transobturator tape (TOT) surgery under local anesthesia versus general anesthesia for female stress incontinent treatment. Chung-Ang journal of medicine. 2011 Dec; 36(3):61-69
81. Jung SH, Choi SY, Kim JY, Lee SH, Chung JD, Choi JW, Chang IH. Temporary Vena Cava Filter Placement to Prevent Tumor Emboli During Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma. Chung-Ang journal of medicine. 2010 Dec;35(3):61-66
82. Kim JH, Kwon JK, Chang IH, Current Opinions Regarding Defense Mechanisms during Urinary Tract Infection Korean J Urogenit Tract Infect Inflamm 2013;8(2): 63-72
83. Kwon JK, Kim SJ, Kim JH, Lee KM, Chang IH, Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer. Urol Oncol 2014
84. Kim SJ, Kim JH, Jung HS, Lee TJ, Lee KM, Chang IH, Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence. Asian J Androl. 2014 Mar 11
85. Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chi BH, Chang IH, Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the Mammalian target of rapamycin signaling pathway. J Korean Med Sci. 2014 Mar;29(3):343-50
86. Chi BH, Chang IH, Current understanding of bladder immune response to BCG therapy. The Korean Journal of Urological Oncology. 2014
87. Chung JD, Lee JB, Lee TJ, Kwon JK, Kin JH, Chang IH, Kim KD, Histopathological differences between prostate cancer foci that are detected and missed using multiparametric magnetic resonance imaging in Korean patients. IJU 2014
88. Min-kyoung Kim, Hyun Kang, Chong Wha Baek, Yong Hun Jung, Young-Cheol Woo, Hwa-Yong Shin, and In-ho. Chang. Apnothorax during urologic laparoscopic surgery ?A case report? Anesth Pain Med 2014; 9: 73-76
89. Seo Yeon Lee, Hae jong Kim1, In Ho Chang2, June Hyun Han3, Kyung Do Kim2, Young Tae Moon2, Soon Chul Myung2,4 Modulation of Antimicrobial Peptide Human β-defensin-3 by Toll-like Receptor Ligands in Vaginal Epithelial Cells. Korean J Urogenit Tract Infect Inflamm 2014; 9 (1) :27-33
90. Min Su Kim1, Tae-Jin Lee2, Hee-Jun Kim3, Sung Bin Park4, Jin Hwa Choi5, In Ho Chang6 Primary Synovial Sarcoma of the Kidney with Unusual Recurrence: Ureteral Stump Recurrence after Radical Nephrectomy Korean J Urol Oncol 2014;12(2):89-94
91. Mack Shin ? Sung Bin Park ? Jong Beum Lee ? Hyun Jeong Park ? In Ho Chang ? Tae-Jin Lee. Unilateral renal oncocytosis and combined hybrid tumor: a case report and review of the literature. Jpn J Radiol (2014) 32:556?560
92. A prospective korean multicenter study for infectious complications in patients undergoing prostate surgery: risk factors and efficacy of antibiotic prophylaxis. Hwang EC, Jung SI, Kwon DD, Lee G, Bae JH, Na YG, Min SK, Son H, Lee SJ, Chung JM, Chung H, Cho IR, Kim YH, Kim TH, Chang IH. J Korean Med Sci. 2014 Sep;29(9):1271-7.
93. Pilot study of low-dose nonenhanced computed tomography with iterative reconstruction for diagnosis of urinary stones. Park SH, Kim KD, Moon YT, Myung SC, Kim TH, Chang IH, Kwon JK. Korean J Urol. 2014 Sep;55(9):581-6.
94. Predicting Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer in Korean Patients: A Comparison of the EORTC and CUETO Models. Choi SY, Ryu JH, Chang IH, Kim TH, Myung SC, Moon YT, Kim KD, Kim JW. Korean J Urol. 2014 Oct;55(10):643-9.
95. Febrile urinary tract infection after prostate biopsy and quinolone resistance. Choi JW, Kim TH, Chang IH, Kim KD, Moon YT, Myung SC, Kim JW, Kim MS, Kwon JK. Korean J Urol. 2014 Oct;55(10):660-4.
96. Voiding characteristics and related hormonal changes inperi-menopausal and post-menopausal women: A preliminary study. Jong Kyu Kwona, Jae Heon Kimb,?, Hoon Choic, In Ho Changa, Bo Ra Parkd,Soon-Sun Kwone, Eun Sil Leed, Gyu Yeon Choid, Jeong Jae Leed, Im Soon Lee. Maturitas 2014 Nov;79:311-5
97. P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model. Chi BH, Kim SJ, Seo HK, Seo HH, Lee SJ, Kwon JK, Lee TJ, Chang IH. J Korean Med Sci. 2015 Mar;30(3):308-16.
98. Usefulness of Low-dose Nonenhanced Computed Tomography With Iterative Reconstruction for Evaluation of Urolithiasis: Diagnostic Performance and Agreement between the Urologist and the Radiologist. Kwon JK, Chang IH, Moon YT, Lee JB, Park HJ, Park SB. Urology. 2015 Mar;85(3):531-8.
99. Modulating the internalization of bacille calmette-guerin by cathelicidin in bladder cancer cells. ,Choi SY, Kim SJ, Chi BH, Kwon JK, Chang IH. Urology. 2015 Apr;85(4):964.e7-964.e12.
100. Murine β-defensin-2 may regulate the effect of bacillus Calmette-Guerin (BCG) in normal mouse bladder. Kwon JK, Chi BH, Choi SY, Kim SJ, Lee TJ, Kim K, Chang IH. Urol Oncol. 2015 Mar;33(3):111.e9-111.e16.
101. Sonographic findings of prescrotal superficial angiomyxoma.Lee CU, Park SB, Lee JB, Park HJ, Kim MK, Chang IH. Jpn J Radiol. 2015 Apr;33(4):216-9.
102. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women. Park M, Chang IH, Kang H, Han SS. J Obstet Gynaecol Res. 2015 May;41(5):784-9
103. Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors. Choi SY, Chang IH. Korean J Urol Oncol. 2015 Apr;13(1):1-10.
104. Establishment of Reference Ranges for Prostate Volume and Annual Prostate Volume Change Rate in Korean Adult Men: Analyses of a Nationwide Screening Population. Park J, Lee DG, Suh B, Cho SY, Chang IH, Paick SH, Lee HL. J Korean Med Sci. 2015 Aug;30(8):1136-42
105. The Internalization of Bacillus Calmette-Guerin (BCG) in Bladder Cancer Cells May be Inhibited by Human beta-defensin 3. Lim SW, Chang IH, Kim TH, Myung SC, Kim KD, Moon YT, Kim JW, Chi BH. Korean J Urol Oncol. 2015 Aug;13(2):75-84. English.
106. Usefulness of Nonenhanced Computed Tomography for Diagnosing Urolithiasis without Pyuria in the Emergency Department. Lee DH, Chang IH, Kim JW, Chi BH, Park SB. Biomed Res Int. 2015;2015:810971.
107. CT for evaluation of urolithiasis: image quality of ultralow-dose (Sub mSv) CT with knowledge-based iterative reconstruction and diagnostic performance of low-dose CT with statistical iterative reconstruction. Hur J, Park SB, Lee JB, Park HJ, Chang IH, Kwon JK, Kim YS. Abdom Imaging. 2015 Oct;40(7):2432-40.
108. Molecular Defense Mechanisms during Urinary Tract Infection. Urogenit Tract Infect. Choi SY, Chang IH. 2015 Oct;10(2):57-66.
109. Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study.Shim SR, Kim JH, Chang IH, Shin IS, Hwang SD, Kim KH, Yoon SJ, Song YS. Yonsei Med J. 2016 Mar;57(2):407-18.
110. Daily Mean Temperature Affects Urolithiasis Presentation in Seoul: a Time-series Analysis. Lee S, Kim MS, Kim JH, Kwon JK, Chi BH, Kim JW, Chang IH. J Korean Med Sci. 2016 May;31(5):750-6.
111. Human Neural Stem Cells Overexpressing a Carboxylesterase Inhibit Bladder Tumor Growth. Choi SS, Chi BH, Chang IH, Kim KD, Lee SR, Kim SU, Lee HJ. Mol Cancer Ther. 2016 Jun;15(6):1201-7.
112. Genetically Modified Bacteria as Targeted Agent for Cancer. Jin S, Whang YM, Chang IH. Korean J Urol Oncol. 2016 Aug;14(2):54-62.
113. Recombinant Bacille Calmette?Guerin for Immunotherapy in Nonmuscle Invasive Bladder Cancer. Jin S, Whang YM, Chang IH. Korean J Urol Oncol. 2016 Dec;14(3):109-117.
114. Urbanization may affect the incidence of urolithiasis in South Korea. Choi SY, Lee SY, Chi BH, Kim JW, Kim TH, Chang IH. Springerplus. 2016 Oct 28;5(1):1891.
저서
전립선암진료지침 (2015)
전립선바로알기 (2014)
요로생식시감염 (2013)
20부터 준비하는 100세를 사는 법 (2011)
남성건강의 신호등 전립선 (2011)
전립선비대증 진료지침 (2010)
전립선바로알기 (2014)
요로생식시감염 (2013)
20부터 준비하는 100세를 사는 법 (2011)
남성건강의 신호등 전립선 (2011)
전립선비대증 진료지침 (2010)
보도자료
최근들어 소변 참기 힘든 흡연자···’방광암’ 의심
http://health.chosun.com/site/data/html_dir/2020/02/21/2020022102910.html
중앙대병원 장인호 교수, 대한비뇨의학회서 우수연제발표상 수상
http://www.k-health.com/news/articleView.html?idxno=46138
[건강100세] 전립선암 잡는 다빈치 로봇
http://www.etoday.co.kr/news/view/1816088
http://health.chosun.com/site/data/html_dir/2020/02/21/2020022102910.html
중앙대병원 장인호 교수, 대한비뇨의학회서 우수연제발표상 수상
http://www.k-health.com/news/articleView.html?idxno=46138
[건강100세] 전립선암 잡는 다빈치 로봇
http://www.etoday.co.kr/news/view/1816088
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
E-Cadherin (CDH1) 유전자를 이용한 전립선암 감수성 진단용 마커 및 예후 예측 마커 (2013)
멜라토닌을 유효성분으로 포함하는 방광평활근의 전압 의존성 칼슘 채널 길항용 조성물 (2010)
멜라토닌을 유효성분으로 포함하는 방광평활근의 전압 의존성 칼슘 채널 길항용 조성물 (2010)